高级搜索
NY-ESO-1与MAGE-A1在乳腺癌组织中的表达及意义[J]. 肿瘤防治研究, 2012, 39(06): 698-700. DOI: 10.3971/j.issn.1000-8578.2012.06.021
引用本文: NY-ESO-1与MAGE-A1在乳腺癌组织中的表达及意义[J]. 肿瘤防治研究, 2012, 39(06): 698-700. DOI: 10.3971/j.issn.1000-8578.2012.06.021
Expression and Significance of Antigens NY-ESO-1 and MAGE-A1 in Breast Carcinoma Tissue[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 698-700. DOI: 10.3971/j.issn.1000-8578.2012.06.021
Citation: Expression and Significance of Antigens NY-ESO-1 and MAGE-A1 in Breast Carcinoma Tissue[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 698-700. DOI: 10.3971/j.issn.1000-8578.2012.06.021

NY-ESO-1与MAGE-A1在乳腺癌组织中的表达及意义

Expression and Significance of Antigens NY-ESO-1 and MAGE-A1 in Breast Carcinoma Tissue

  • 摘要: 目的 探讨NY-ESO-1与MAGE-A1在乳腺癌组织中的表达及意义。方法 健康对照者乳腺组织20例,不同病理类型及分级的病例90例,标本进行免疫组织化学SP法染色;采用Tanaka改良定量记分法测阳性率。结果 NY-ESO-1与MAGE-A1在正常乳腺组织中不表达;乳腺癌组织中NY-ESO-1与MAGE-A1阳性表达率分别为37.78%和23.33%;阳性表达与临床病理各参数不具有相关性(P>0.05)。结论 NY-ESO-1和MAGE-A1在乳腺癌组织中呈高特异性表达,对乳腺癌的早期诊断有一定的临床意义。

     

    Abstract: Objective To study the expressions of cancer/testis antigens NY-ESO-1 and MAGE-A1 in breast carcinoma tissue. Methods According to pathological grade and pathologic type,90 breast cancer patients were studied,20 cases of normal breast gland as a control group.Immunohistochemical SP method was performed to detect the expression of antigens NY-ESO-1 and MAGE-A1 and the positive rate was measure by Tanaka-improved quantitative scoring method. Results There was no expression in normal breast tissue.The positive expression rate of NY-ESO-1 and MAGE-A1 was 37.78% and 23.33% respectively in breast cancer tissue,and had no obvious relevance to clinical pathological features (P>0.05) ConclusionNY-ESO-1 and MAGE-A1 were expressed with high specificity in breast carcinoma tissue,have slightly clinical significance in diagnosis and immunotherapy of breast carcinoma.

     

/

返回文章
返回